Back to News
Market Impact: 0.12
Ebola Vaccine Race Expands as Congo Bundibugyo Outbreak Grows
Source: Bloomberg
Pandemic & Health EventsHealthcare & BiotechTechnology & Innovation
Vaccine development against the Ebola strain driving the Democratic Republic of Congo outbreak is accelerating, with an experimental shot from an Egypt-based pharmaceutical company moving toward human testing. While the situation remains deadly, the step toward human trials is a constructive milestone for the program.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.15
More News
- Musk says Terrafab chip factory could outperform rivals despite challenges
- Nvidia GPUs are everywhere. Here are the ways companies are accessing them
- Stocks saw new highs and big declines: How the volatile AI trade moved last week's market
- Nvidia in talks to acquire Reflection AI or increase investment, FT reports
- AI's Supercharging a Scam Economy Bigger Than the Cocaine Trade
- Microsoft's Nadella says AI needs an ‘emergency brake’ that humans control